ZFGN Zafgen Inc.

1.44
+0.03  (+2%)
Previous Close 1.41
Open 1.41
Price To Book 0.65
Market Cap 53,564,094
Shares 37,326,895
Volume 8,808
Short Ratio
Av. Daily Volume 279,243

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Noted May 30, 2019 that clinical hold has yet to be resolved.
ZGN-1061
Diabetes
Announced July 2016 suspension of development of Beloranib
Beloranib
Severe obesity
Announced July 2016 suspension of development of Beloranib
Beloranib
Prader-Willi Syndrome (PWS)
Announced July 2016 suspension of development of Beloranib
Beloranib
Severe obesity

Latest News

  1. Zafgen to Present at the JMP Securities Life Sciences Conference
  2. Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific Sessions
  3. Micro-Cap Biotech Zafgen Plunges To Record Low: What You Need To Know
  4. Zafgen Announces Regulatory Update on ZGN-1061
  5. Zafgen: 1Q Earnings Snapshot
  6. Zafgen Reports First Quarter 2019 Operating and Financial Results
  7. Zafgen to Announce First Quarter 2019 Financial Results
  8. Zafgen, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
  9. Edited Transcript of ZFGN earnings conference call or presentation 11-Mar-19 9:00pm GMT
  10. Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., iRhythm Technologies, Inc., Orion Group Holdings, Inc., Osmotica Pharmaceuticals plc, Quantenna Communications, Inc., WABCO Holdings, Inc. and Zafgen, Inc.
  11. INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Zafgen, Inc. Investors
  12. Glancy Prongay & Murray LLP Announces Investigation on Behalf of Zafgen, Inc. Investors
  13. What Do Investors Need To Know About Zafgen, Inc.’s (NASDAQ:ZFGN) Growth?
  14. Zafgen to Present at the 31st Annual ROTH Conference
  15. Biotech Stock Roundup: REGN Gets FDA Nod for Dupixent & Other Pipeline News
  16. The Daily Biotech Pulse: Zafgen Won't File IND For Metabolic Disorder Drug, Positive Results For Akebia's Anemia Drug
  17. Zafgen shelves another drug; chief medical officer exits